Satoshi Saida

14PUBLICATIONS
91CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Rheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 25, 2026
Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Jan 06, 2026
Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Katsutsugu Umeda, Satoshi Saida, Hirokazu Kobushi

|Nov 02, 2025
Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Yuta Katai, Tatsuya Kamitori, Satoshi Saida

|Apr 29, 2024
Juvenile xanthogranuloma manifesting with LCH-associated neurodegenerative disease-like radiological findings.

Tomoo Daifu, Katsutsugu Umeda, Atsushi Yokoyama

|Mar 21, 2024
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki

Pageof 3

Frequent Collaborators

11 joint publications

Katsutsugu Umeda

10 joint publications

Itaru Kato

7 joint publications

Hirohito Kubota

6 joint publications

Junko Takita